Cochlear Implant Bilateral denied for failing step therapy by Blue Cross Blue Shield?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for cochlear implant bilateral are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on Cochlear Implant Bilateral
## Why BCBS Imposes Step Therapy for Bilateral Cochlear Implants
Step therapy — sometimes called "fail-first" — requires a patient to try and document inadequate response to a less intensive intervention before the plan will approve a more advanced one. For bilateral cochlear implantation, BCBS's step-therapy policy typically requires documented prior use of appropriately fitted hearing aids in both ears, with formal audiological documentation that the hearing aids provided inadequate benefit. In some cases, plans also require a trial with a unilateral cochlear implant before approving the second implant. The denial arises when the submitted records do not include sufficient documentation of these prior steps.
## Why This Denial Is Appealable
Step therapy requirements are subject to medical-necessity exceptions in most states and under most BCBS plans. An exception is available when prior steps are contraindicated, when the patient has already completed the required steps and the documentation was not submitted, or when requiring the steps would cause clinically significant harm or delay. Many states have enacted step-therapy reform laws that establish explicit timelines and exception criteria — these apply to state-regulated (fully insured) BCBS plans.
## Your Federal Appeal Rights
- Step-therapy exception request: File this alongside or before your formal appeal. Explain why the required prior step(s) are already completed, contraindicated, or not appropriate for this patient.
- Internal appeal: If the required steps have already been completed and documented, the denial is likely based on missing records rather than a true failure to meet criteria. Submit the complete hearing aid trial records.
- State step-therapy reform law: Many states require plans to respond to exception requests within defined timeframes (often 72 hours for urgent cases). Check your state's insurance department website for applicable requirements.
- External review (ACA §2719): Available after internal appeal exhaustion, and on an expedited basis when health is at risk.
- ERISA §503: Employer plan members are entitled to the specific step-therapy protocol used and all criteria for exceptions.
- Timeline: Internal appeal: typically 180 days from denial. External review: generally four months from final internal denial.
## Documentation to Gather
- Hearing aid trial records for both ears: Dates of fitting, devices used, dispensing audiologist's notes, real-ear measurement results, follow-up visits, and the audiologist's formal assessment of inadequate benefit. Both ears must be documented independently.
- Audiological candidacy evaluation: Formal audiological testing establishing hearing loss severity in each ear that meets cochlear implant candidacy criteria per the applicable professional guidelines.
- Prescriber letter addressing step-therapy exception: A letter from the ENT surgeon or audiologist explaining why the required prior steps have been completed (or why they are not applicable), and why further delay of bilateral cochlear implantation would be medically inappropriate.
- Prior unilateral implant outcome records (if applicable): If the step requires a trial with a unilateral implant, provide outcome data from that implant and the clinical rationale for proceeding to bilateral.
## Criteria-Mapping Structure
Obtain BCBS's step-therapy protocol for cochlear implantation and map each required step to the patient's record:
| Required Step-Therapy Step | Documentation Demonstrating Completion or Exception Basis | |---|---| | [List each required step from the BCBS protocol verbatim] | [Cite chart notes, audiological reports, and dates that satisfy each step] |
Address every step explicitly. A response that leaves any step unanswered will be denied again on the same grounds.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied for failing step therapy of 17ohp Compounded
- Blue Cross Blue Shield denied for failing step therapy of AAT Augmentation
- Blue Cross Blue Shield denied for failing step therapy of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied for failing step therapy of Anti Cd 20 Ocrevus